BDBM50138859 CHEMBL157430::[(S)-3-Methyl-1-(thiophen-2-ylmethyl)-aminooxalyl]-butyl)-carbamic acid 1-isopropyl-2-methyl-propyl ester
SMILES: CC(C)C[C@H](NC(=O)OC(C(C)C)C(C)C)C(=O)C(=O)NCc1cccs1
InChI Key: InChIKey=UZJJBVNFVOFOGM-INIZCTEOSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cathepsin K (Homo sapiens (Human)) | BDBM50138859![]() (CHEMBL157430 | [(S)-3-Methyl-1-(thiophen-2-ylmethy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Concentration required to inhibit 50% of cysteine protease cathepsin K of human | J Med Chem 47: 588-99 (2004) Article DOI: 10.1021/jm030373l BindingDB Entry DOI: 10.7270/Q29S1QF7 | |||||||||||
More data for this Ligand-Target Pair |